lockdown offset by improving bad debt expense. Net FX loss was Bt181mn in 3Q20, turned negative, compared to FX gain of Bt344mn in 2Q20 as THB had depreciated against USD and increased capex payable. Finance
and the Diplomat 39 which is a project purchased for sale • Net debt to Equity ratio2 as of 31 March 2019 equals 0.84 times Changes in accounting policy and reclassification in 1Q/19 During the three
14,329.7mn, an increase of THB 3,871.8mn from the previous year • Net debt to Equity ratio3 as of 31 December 2018 equals 0.96 times Operating result Q4/18 and 2018 Revenue and Backlog2 Source of income (Unit
the first six months of 2020, finance cost amounted to Baht 608.67 million, up by Baht 21.74 million or 3.70% from the same period of last year as a result of more bank loans. Net interest-bearing debt
Total liabilities (excl. Qualified Sub-Debt) Net Capital Illiquid https://www.sec.or.th/TH/Documents/Intermediaries/seminar-nc.pdf แบบพิจารณาระบบงานของผู้รับใบอนุญาต security) เช่น - การให้ความรู้ - การ
Bt109,700mn with a net debt to EBITDA of 1.4x, stable from 2016, and maintained an investment grade credit rating at BBB+ for S&P. Cash Flow In 2017, AIS generated Bt65,528mn of operating cash flow ( after tax
+3.3% from retained earnings. Net debt to EBITDA (excluding lease liabilities and license payable) was 0.7x slightly decline compared to 4Q19. Cash flow (Post TFRS 9&16) In 1H20, Cash flow from operating
Bt250,467mn, declining -0.3% from the end of 2022. Interest-bearing debt stood at Bt80,790mn, decreased by -4.3% following the debt repayment. Net debt to EBITDA (excluding lease liabilities and license payable
million or 10.42% from 2017 because of decreased average cost of debt and bank loan repayment. Net-Debt-to-Equity ratio according to the Company’s consolidated financial statement as of December 31, 2018
, decreasing by Baht 98.10 million or 9.34% from the same period of 2017 because of decreased average cost of debt. Net-Debt-to-Equity ratio according to the Company’s consolidated financial statement as of